MOTA is a free digital companion that converts a BRCA1 or BRCA2 test result into a personalized, evidence‑based care roadmap covering screening schedules, risk‑reduction options, and family‑planning considerations.
Funding
Funding not disclosed
Founders
Product
Problem
Women who test positive for a BRCA1 or BRCA2 mutation receive genetic results but often lack clear guidance on how to manage their increased cancer risk, leading to uncertainty about screening, preventive options, and family‑planning decisions.
Solution
MOTA offers a free digital companion that transforms a BRCA test result into a personalized care roadmap. Users answer brief questions about their result and health history, and the platform generates an evidence‑based plan that outlines recommended screening schedules, risk‑reduction strategies, and family‑planning considerations. A curated directory connects users with vetted hereditary‑cancer specialists, allowing them to filter by location and expertise. An integrated timeline tool lets users schedule appointments, track screenings, and set reminders, keeping their care organized in one place. Real‑world stories from other BRCA‑positive women provide peer support and practical insights.
Target Audience
Primary users are women who have tested positive for a BRCA1 or BRCA2 mutation and are seeking structured guidance and specialist referrals for cancer risk management.
Features
- Personalized, evidence‑based care plan generated from BRCA result and health inputs
- Curated specialist directory with genetic counselors, gynecologic oncologists, and breast surgeons
- Timeline and reminder system for appointments, screenings, and follow‑up tasks
- Peer‑support stories from women navigating similar BRCA journeys
- Free-to‑use platform with no subscription barriers